| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, CFO, Cbo &Treasurer | Interim CEO, President and CFO | Chief Financial Officer
2 companies
Ostrowski Erik serves as a SVP, CFO, Cbo &Treasurer at AKBA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $720K at current prices.
The biggest single holding is AKBA (~$684K) as SVP, CFO, Cbo &Treasurer. The recent filings there lean toward selling, a net 132,284 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | AKBA Akebia Therapeutics, Inc. | SVP, CFO, Cbo &Treasurer | Sell10b5-1 | 56,019 | $1.11 | $62,181.09 | -8.3% | -19.5% | - | |
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | SVP, CFO, Cbo &Treasurer | Sell10b5-1 | 34,951 | $1.39 | $48,581.89 | -4.9% | +8.7% | - | |
| Jun 30, 2025 | AKBA Akebia Therapeutics, Inc. | SVP, CFO, Cbo &Treasurer | Sell10b5-1 | 41,314 | $3.67 | $151,622.38 | -7.6% | -25.5% | - |